Stay updated on Cladribine, Idarubicin & Cytarabine for AML Clinical Trial
Sign up to get notified when there's something new on the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page.
Latest updates to the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page
- Check3 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new addition was made on December 24, 2024, while a deletion occurred on June 20, 2024.SummaryDifference0.6%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check39 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has added new features for data selection and download options, while several key government health-related URLs have been removed.SummaryDifference14%
- Check67 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links including those to HHS, NIH, and NLM, while the previous version 2.12.1 has been removed.SummaryDifference17%
Stay in the know with updates to Cladribine, Idarubicin & Cytarabine for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page.